AmyBrooks-KayalMDFAAN, FAES, FANA

PubMed

• 29 citations
  Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette.
  Kevin E. Chapman, Yogendra H. Raol, Amy R. Brooks-Kayal
  The European Journal of Neuroscience. 2012-06-01
• 573 citations
  Selective changes in single cell GABA A receptor subunit expression and function in temporal lobe epilepsy
  Amy R. Brooks-Kayal, Melissa D. Shumate, Hong Jin, Tatiana Y. Rikhter, Douglas A. Coulter
  Nature Medicine. 1998-10-01
• 38 citations
  Aggrecan expression, a component of the inhibitory interneuron perineuronal net, is altered following an early-life seizure.
  Paulette A. McRae, Esther Baranov, Shilpa Sarode, Amy R. Brooks-Kayal, Brenda E. Porter
  Neurobiology of Disease. 2010-09-01

Lectures

• Your Grant was Rejected. Now What? 
  Los Angeles, CA - 1/1/2018
• Women in Neuroscience 
  Los Angeles, CA - 1/1/2018
• Getting from Mechanisms to Therapies: New Treatments on the Horizon for Epilepsy 
  Orlando, FL, 2018; Trinidad, 2018 - 1/1/2018
• Getting from mechanism to medicine: Insights from an academic�s journey into translational epilepsy research 
  New Haven, CT, 2016; New York, NY, 2017 - 1/1/2017
• Getting from mechanism to medicine: Opportunities and Challenges in the development of new therapies for epilepsy 
  Layfayette, IN - 1/1/2017
• Epilepsy at the Cutting Edge: Using Novel Models for Therapeutic Advances 
  Boston, MA - 1/1/2017
• From Mechanism to Medicine: Modifying signaling pathways to prevent post-traumatic epilepsy 
  Denver, CO - 1/1/2017
• Neurobehavioral Co-morbidities in Pediatric Epilepsy 
  Linkoping, Sweden - 1/1/2017
• Advances in Translational Epilepsy 
  Linkoping, Sweden - 1/1/2017
• Epilepsy at the Cutting Edge: using novel models and innovative approaches to make therapeutic advances 
  Washington, DC - 1/1/2017
• BDNF & JAK/STAT Regulation after Brain Injuries Potential New Targets for Disease Modification for Acquired Epilepsy? 
  University of Aix-Marseille, Marseille, France - 1/1/2016
• JAK/STAT Regulation after Brain Injuries Potential New Targets for Disease Modification for Acquired Epilepsy? 
  Waco, TX - 1/1/2016
• Cannabinoids for Treatment of Pediatric Epilepsy: The Hype And The Evidence 
  NIH Campus, Bethesda, MD - 1/1/2016
• Getting to Cure: Opportunities and Challenges on the Road to Disease Modifying Therapies for Epilepsy 
  Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA - 1/1/2016
• JAK/STAT Regulation after Brain Injury: Potential New Targets for Disease Modification 
  Breckenridge, CO - 1/1/2016
• Cannabinoids 
  Washington DC - 1/1/2015
• Getting to Cure: Opportunities and Challenges on the Road to Disease Modifying and Preventative Therapies for Epilepsy 
  Boston University, Department of Pharmacology - 1/1/2015
• Comorbid Cognitive and Neuropsychiatric Disorders of Epilepsy and CNS Disorders with Seizures 
  Park City Utah - 1/1/2015
• Regulating aberrant plasticity after brain injury; following novel pathways to find new treatments 
  Taormina, Sicily, Italy - 1/1/2015
• Animal Models of Epilepsy Co-Morbidities: What do they tell us about mechanisms 
  Istanbul, Turkey - 1/1/2015
• JAK/STAT pathway activation as a molecular biomarker of epileptogenesis and cognitive co-morbidities after brain injury 
  Heybeliada Island, Istanbul, Turkey - 1/1/2015
• Strategic Planning 
  Istanbul, Turkey - 1/1/2015
• The challenge and promise of developing disease modifying therapies for epilepsy 
  Washington, DC - 1/1/2015
• BDNF and JAK/STAT regulation after brain injury: potential new targets for disease modification in epilepsy 
  Estes Park, CO - 1/1/2015
• Why make the journey: The need for disease modifying and preventative therapies for epilepsy 
  Philadelphia, PA - 1/1/2015
• Join now to see all